SIGN UP
LOG IN
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·07/03/2025 17:07:08
Listen to the news
Gainers
- Regencell Bioscience (NASDAQ:RGC) stock moved upwards by 120.3% to $22.82 during Thursday's regular session. The market value of their outstanding shares is at $5.1 billion. As per the news, the H1 earnings report came out 3 days ago.
- Lixte Biotechnology (NASDAQ:LIXT) shares increased by 41.48% to $2.86. The market value of their outstanding shares is at $5.5 million.
- Vor Biopharma (NASDAQ:VOR) stock moved upwards by 31.37% to $1.91. The market value of their outstanding shares is at $181.1 million.
- Jupiter Neurosciences (NASDAQ:JUNS) shares rose 31.14% to $1.56. The company's market cap stands at $39.3 million.
- Know Labs (AMEX:KNW) stock rose 27.97% to $2.47. The market value of their outstanding shares is at $14.3 million.
- Cognition Therapeutics (NASDAQ:CGTX) stock moved upwards by 23.53% to $0.41. The market value of their outstanding shares is at $20.7 million.
Losers
- Inovio Pharmaceuticals (NASDAQ:INO) shares declined by 37.9% to $1.33 during Thursday's regular session. The company's market cap stands at $78.4 million.
- Jyong Biotech (NASDAQ:MENS) shares decreased by 17.68% to $7.92. The company's market cap stands at $731.3 million.
- OneMedNet (NASDAQ:ONMD) shares decreased by 11.74% to $0.56. The company's market cap stands at $28.4 million.
- GT Biopharma (NASDAQ:GTBP) stock fell 11.34% to $2.75. The company's market cap stands at $9.7 million.
- Venus Concept (NASDAQ:VERO) stock fell 10.54% to $2.64. The market value of their outstanding shares is at $5.4 million.
- Zynex (NASDAQ:ZYXI) shares declined by 10.41% to $2.41. The company's market cap stands at $81.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.